Cystatin C: early laboratory marker of renal disease in sickle cell disease

Maydelin Miguel Morales; Olga M Agramonte Llánes; Yaima Urrutia Febles; Maydí Fundora Cedeño

2018, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2018; 34 (2)

Cystatin C: early laboratory marker of renal disease in sickle cell disease

Miguel MM, Agramonte LOM, Urrutia FY, Fundora CM

Full text

How to cite this article

Language: Spanish
References: 0
Page: 125-130
PDF size: 160.32 Kb.

ABSTRACT

Renal disease in patients with sickle cell disease is a consequence of its complex pathophysiological process, so it is important to have a set of laboratory parameters that, together with the clinical evaluation, allow the early detection of this complication. Cystatin C has been shown to be one of the parameters that provides, with greater accuracy, early evidence of kidney damage in this group of patients and at the same time constitutes a possible indicator of prognosis of great importance.